MAXHEALTH and FORTIS, both in Hospital/Nursing Management. Monthly data through 2026-10-09. Change the comparison →
Share price change since Aug '20, the first month all 2 have a price: MAXHEALTH +731%, FORTIS +492%.
Rebased at 2020-08. Monthly closes from each company's history.
Months with a missing value are left as gaps.
The share price return over 3 years, split into net profit growth, share count change and the change in P/E.
MAXHEALTH: share price rose 54% over 3 years: +4 pts from net profit growth, +50 pts from the P/E change.
FORTIS: share price rose 144% over 3 years: +138 pts from net profit growth, +5 pts from the P/E change, +1 pts from share count change.
Segments are percentage points of the price return: price = P/E × net profit ÷ share count. These are the same numbers each company's own page shows.
Each cell is the company's percentile rank among its own sector peers that month. Darker is higher-ranked. Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value.
| Metric | MAXHEALTH | FORTIS |
|---|---|---|
| Share Price | ₹883.80 | ₹786.25 |
| Market Cap | ₹85985 cr | ₹59231 cr |
| P/E | 119.8x | 262.1x |
| P/B | 9.6x | 6.4x |
| P/S | 29.0x | 32.0x |
| ROCE | 10.0% | 4.0% |
| ROE | 8.0% | 2.4% |
| Operating margin | 23.0% | 21.0% |
| Revenue (TTM), indexed to 100 | ₹2964 cr | ₹1849 cr |
| Net Profit (TTM) | ₹718 cr | ₹226 cr |
| Debt / Equity | 0.1x | 0.2x |
| Cash Conversion Cycle | -94d | -332d |
| Promoter holding | 23.7% | 31.2% |
| FII Holding | 41.8% | 25.2% |
| DII Holding | 29.9% | 32.2% |
| 12M momentum | -23.0% | -23.2% |
| Drawdown from Peak | -30.7% | -23.2% |
| Cash conversion (3Y) | 0.8x | 1.4x |
| Interest cover | 22.5x | 2.3x |
| Share Count Change (1Y) | 0.1% | 0.0% |
| Volatility (1Y) | 27.3% | 27.0% |
Latest month in the data: 2026-10. Highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment.
Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment. Not investment advice; ApnaFunda is not a SEBI-registered research analyst.